Trainee Editorial Board

Our Trainee Editorial Board members are early career researchers (postdoctoral), or clinicians and other health professionals on an approved training scheme in a cancer-related discipline. Members are paired with a member of the regular Editorial Board who will act as a mentor on peer review and the publishing process over the course of the 2-year term. 

An expectation of Trainee Editorial Board members is the submission of one editorial-style paper to the journal, during the 2-year term, on “Lessons from practice-changing papers,” which will focus on a past landmark paper in their chosen field and be co-written with their senior Editorial Board mentor.

We are accepting applicants to the Trainee Editorial Board on a rolling basis. Interested applicants should apply using this Google Form.

Trainee Editorial Board members


Edward Christopher, MBChB, University of Leeds, UK
Interests: CNS cancers, frailty in oncology, systematic reviews, meta-analyses, population-based studies, evidence-based medicine

Rachel Keogh, MB BCh BAO, Cork University Hospital, Ireland
Interests: Medical oncology, thoracic oncology, oncogenomics, immunotherapy, clinical trials

Alok Mishra, PhD, UMass Chan Medical School, USA
Interests: Ovarian cancer, immunotherapy, drug targets, CRISPR editing, macrophages

Diana Prepelita, MD, University of Medicine and Pharmacy Carol Davila, Romania
Interests: Hereditary cancer syndromes, breast cancer, ovarian cancer, translational medicine, treatment resistance mechanisms, new cancer targeting strategies

Monika Rezacova, MD, Winchester Hospital, UK
Interests: Breast cancer, breast surgery, melanoma, sentinel lymph node, targeted axillary disection

Abhilasha Srivastava, PhD, Medical College of Wisconsin, USA
Interests: Epithelial to mesenchymal transition, metastasis, DNA damage and repair, epigenetics, prostate cancer

Federico Virga, PhD, Spanish National Centre for Cardiovascular Research (CNIC), Spain
Interests: MicroRNA, cancer immunology, cancer metabolism, pancreatic cancer, immunotherapy

Catherine Weadick, MB BCh BAO, MSc, MRCPI, Cork University Hospital, Ireland
Interests: Breast, sarcoma, AYA, gynaecological malignancy, genetics